Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
Journal:
Current Gene Therapy
Volume:
10
Page:
77-90
Author(s):
John S. Bridgeman, Robert E. Hawkins, Andreas A. Hombach, Hinrich Abken and David E. Gilham
Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1376-1386
Author(s):
Sabrina Burattini, Michela Battistelli and Elisabetta Falcieri
Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1396-1409
Author(s):
V. Cepero, J. R. Sierra and S. Giordano
Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1313-1355
Author(s):
Lin-Lin Wang, An-Kui Yang, Shu-Ming He, Jun Liang, Zhi-Wei Zhou, Yong Li and Shu-Feng Zhou
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium
Journal:
Current Topics in Medicinal Chemistry
Volume:
10
Page:
504-526
Author(s):
Andrea Cappelli, Stefania Butini, Antonella Brizzi, Sandra Gemma, Salvatore Valenti, Germano Giuliani, Maurizio Anzini, Laura Mennuni, Giuseppe Campiani, Vittorio Brizzi and Salvatore Vomero
Recognition of Single Stranded and Double Stranded DNA/RNA Sequences in Aqueous Medium by Small Bis-Aromatic Derivatives
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
299-308
Author(s):
L.-M. Tumir and I. Piantanida
Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Journal:
Current Proteomics
Volume:
7
Page:
1-14
Author(s):
Hari R. Kumar, Xiaoling Zhong, Robert J. Hickey, Linda H. Malkas and John A. Sandoval
Impact of the CD40-CD40L Dyad in Alzheimers Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
149-155
Author(s):
Brian Giunta, Kavon Rezai-Zadeh and Jun Tan
Assessing Activation States in Microglia
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
174-191
Author(s):
Carol A. Colton and Donna M. Wilcock
Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
217-231
Author(s):
G. Hoffner, W. Andre, A. Vanhoutteghem, S. Soues and P. Djian